The imaging division of GE HealthCare has been enhanced through the FDA clearance of the new innovation known as True Definition DL. The AI technology used in the creation of the images is based on the use of deep learning which is expected to improve image quality. This reflects the company’s dedication to improving clinical performance using AI technology.
In recent times, radiology remains one of the pillars of healthcare due to the wide range of uses of imaging technology in the care process. As a result, there have been increasing calls for the use of faster and more efficient methods to conduct diagnoses of patients’ conditions. True Definition DL responds to this call through the use of deep neural networks. The improved new solution increases spatial resolution while at the same time reducing image artifacts, thus providing an opportunity for doctors to be able to view finer anatomical details. The solution also offers a high-definition option and a 1024 matrix viewing capability, offering better imaging results. Importantly, the solution makes it possible for doctors to conduct chest high-resolution scans within a second.
This latest development builds upon GE HealthCare’s established deep learning CT ecosystem, which already includes solutions such as TrueFidelity DL and True Enhance DL. By expanding its portfolio, the company is positioning itself to meet the growing global demand for advanced imaging technologies driven by rising chronic disease rates and increasing diagnostic workloads.
Also Read: Flagship Pioneering and AWS Collaborate to Advance AI-Driven Drug Discovery and Life Sciences Innovation
“Image quality matters in healthcare – because when imaging performance is aligned with the specific diagnostic task, it plays a critical role in improving accuracy, enabling earlier detection, and guiding appropriate patient care,” said Chad Rowland, Executive Director of Global Premium CT and Photon Counting at GE HealthCare.
True Definition DL is engineered to overcome traditional trade-offs in CT imaging, where achieving higher resolution often required increased radiation dose or longer scan times. By utilizing AI-driven reconstruction techniques, the solution delivers enhanced image sharpness and diagnostic confidence without disrupting existing clinical workflows.
“For clinicians, diagnostic confidence begins with the ability to clearly visualize subtle structures, differentiate tissues and trust what is seen on the screen,” Chad Rowland, GEHC’S executive director OF Global Premium CT and Photon Counting, said in a statement. “For patients, that clarity can translate into quicker answers, fewer repeat scans and care plans tailored to their specific needs.”
Clinical experts have also emphasized the impact of improved resolution in specialized imaging scenarios. “True Definition DL delivers exceptional spatial resolution for visualizing very small anatomical structures,” shares Stefanie Bitschnau, MD, a radiologist affiliated with Radiomed in Wiesbaden, Germany. “In chest imaging, this level of detail is particularly valuable for assessing small airways, supporting earlier and more confident evaluation of interstitial lung disease. Additionally, the technology is highly beneficial in applications such as inner ear imaging with petrous bone scans, where it allows us to clearly visualize the auditory ossicles and detect erosions at an early stage. This improved definition also supports more confident fracture assessment.”
It can be integrated into GE HealthCare’s Revolution Apex and Revolution Vibe CT systems and works with both newly installed equipment and upgraded existing systems.
In light of the mounting challenges faced by health systems across the globe due to an increasing number of patients with intricate diseases, technologies such as True Definition DL will likely be instrumental in revolutionizing diagnostics. The innovative approach of GE HealthCare, which is based on incorporating intelligence, accuracy, and speed in its technologies, contributes significantly to medical imaging advancements.
